Mesoblast Limited MSB

$ 1.565

0.00 | 0.00

As of 23/04/2019 05:35 PM (20 min delay)

Open Price $1.55	Day Range 1.525-1.57	52-Week Range 2.47-1.01	Market Cap $780 M



Prev Close $1.56	Today's Volume 486,128	Volume - 30 Day Avg 1,231,868	Total Shares Quoted 498.6 M



GICS Sector Health Care	GICS Industry Pharmaceuticals, Biotechnology & Life Sciences	Equity Style Box	Company Profile Download PDF

Quotes and News

Price Chart 23/04/2019 05:35 PM (20 min delay)

Recent News
27 Mar 2019	Mesoblast Enters into Memorandum of Understanding for Confirmatory Trial to Support Marketing Approval of Revascor for Reduction of Gastrointestinal Bleeding in Lvad Patients
25 Mar 2019	Mesoblast Announces Licensee Files for Marketing Approval to Treat Epidermolysis Bullosa
21 Feb 2019	Mesoblast Reports Net Loss of $44.1m for Half-Year to 31 December 2018
21 Feb 2019	Mesoblast Announces Half Year Results and Provides Corporate Update
31 Jan 2019	Mesoblast Reports Positive Cash Flow of $21.91m for the December 2018 Quarter

Premium Content
Morningstar Rating for Stocks
PREMIUM
Uncertainty Rating
PREMIUM
Latest Research Report
PREMIUM
All Research Reports
PREMIUM
Fair Value Estimate
PREMIUM
Economic Moat
PREMIUM
Stewardship Rating
PREMIUM

Premium Pricing Help Advertising Opportunities Licensing Opportunities Glossary FSG Contact Us Careers Research Report Disclosure Research Methodology

International Sites: United States Canada China France Germany Hong Kong Italy The Netherlands Norway Spain U.K.